Low sensitivity, false negativity (e.g., a small HCC with normal AFP level), and false positivity (e.g., liver function damage and certain gastrointestinal tumors) of AFP could lead to decreased chance of early diagnosis and thus poor clinical outcomes, highlighting the requirement for more effective approaches for HCC detection. The gene discussed is AFP; the disease is hepatocellular carcinoma.